241 related articles for article (PubMed ID: 18829575)
1. Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.
Wilson W; Baldwin AS
Cancer Res; 2008 Oct; 68(19):8156-63. PubMed ID: 18829575
[TBL] [Abstract][Full Text] [Related]
2. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD
Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615
[TBL] [Abstract][Full Text] [Related]
4. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells.
Zhang JS; Herreros-Villanueva M; Koenig A; Deng Z; de Narvajas AA; Gomez TS; Meng X; Bujanda L; Ellenrieder V; Li XK; Kaufmann SH; Billadeau DD
Cell Death Dis; 2014 Mar; 5(3):e1142. PubMed ID: 24675460
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.
Sanchez JF; Sniderhan LF; Williamson AL; Fan S; Chakraborty-Sett S; Maggirwar SB
Mol Cell Biol; 2003 Jul; 23(13):4649-62. PubMed ID: 12808104
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.
Mamaghani S; Patel S; Hedley DW
BMC Cancer; 2009 Apr; 9():132. PubMed ID: 19405981
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
[TBL] [Abstract][Full Text] [Related]
8. GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κB.
Bang D; Wilson W; Ryan M; Yeh JJ; Baldwin AS
Cancer Discov; 2013 Jun; 3(6):690-703. PubMed ID: 23547054
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.
Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
HPB (Oxford); 2015 Sep; 17(9):770-6. PubMed ID: 26147011
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.
Steinbrecher KA; Wilson W; Cogswell PC; Baldwin AS
Mol Cell Biol; 2005 Oct; 25(19):8444-55. PubMed ID: 16166627
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
14. Long-term incubation with proteasome inhibitors (PIs) induces IκBα degradation via the lysosomal pathway in an IκB kinase (IKK)-dependent and IKK-independent manner.
Lee KH; Jeong J; Yoo CG
J Biol Chem; 2013 Nov; 288(45):32777-32786. PubMed ID: 24085292
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells.
Hu Y; Gu X; Li R; Luo Q; Xu Y
J Exp Clin Cancer Res; 2010 Nov; 29(1):154. PubMed ID: 21110852
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades.
Wang MJ; Huang HY; Chen WF; Chang HF; Kuo JS
J Neuroinflammation; 2010 Dec; 7():99. PubMed ID: 21194439
[TBL] [Abstract][Full Text] [Related]
17. Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade.
Johnson JL; de Mejia EG
Mol Nutr Food Res; 2013 Dec; 57(12):2112-27. PubMed ID: 23943362
[TBL] [Abstract][Full Text] [Related]
18. Ionizing radiation can induce GSK-3beta phosphorylation and NF-kappaB transcriptional transactivation in ATM-deficient fibroblasts.
Kwon O; Kim KA; He L; Kim SO; Kim MS; Cha EY; Yoon BD; Sok DE; Jung M; Ahn JS; Kim BY
Cell Signal; 2008 Apr; 20(4):602-12. PubMed ID: 18243662
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma.
Bilim V; Ougolkov A; Yuuki K; Naito S; Kawazoe H; Muto A; Oya M; Billadeau D; Motoyama T; Tomita Y
Br J Cancer; 2009 Dec; 101(12):2005-14. PubMed ID: 19920820
[TBL] [Abstract][Full Text] [Related]
20. Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3.
Liu L; Liu Y; Liu X; Zhang N; Mao G; Zeng Q; Yin M; Song D; Deng H
Cancer Sci; 2018 Nov; 109(11):3611-3622. PubMed ID: 30168902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
